




Searching News Database: TAVI
HSMN NewsFeed - 10 Nov 2022
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
HSMN NewsFeed - 28 Jan 2022
FDA Accepts Label Update for Plasma IQ(TM), the First FDA-Cleared Handheld Plasma Energy Device
FDA Accepts Label Update for Plasma IQ(TM), the First FDA-Cleared Handheld Plasma Energy Device
HSMN NewsFeed - 28 Sep 2021
Open Stent Solution closes €2.5M Seed financing round for its breakthrough open-stent TMVR device
Open Stent Solution closes €2.5M Seed financing round for its breakthrough open-stent TMVR device
HSMN NewsFeed - 9 Nov 2020
OrbusNeich(R) Medical and P+F Products & Features(R) announce new partnership
OrbusNeich(R) Medical and P+F Products & Features(R) announce new partnership
HSMN NewsFeed - 28 Sep 2020
Boston Scientific Launches ACURATE neo2(TM) Aortic Valve System in Europe
Boston Scientific Launches ACURATE neo2(TM) Aortic Valve System in Europe
HSMN NewsFeed - 27 Aug 2020
Healeon Announces FDA 510(k) Clearance for Duet Office-Based Blood Separation and Concentration System
Healeon Announces FDA 510(k) Clearance for Duet Office-Based Blood Separation and Concentration System
HSMN NewsFeed - 10 Aug 2020
Werewolf Therapeutics Appoints Business Leader, Ellen Lubman, as Chief Business Officer
Werewolf Therapeutics Appoints Business Leader, Ellen Lubman, as Chief Business Officer
HSMN NewsFeed - 6 May 2020
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN(R) Intellectual Property Litigation
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN(R) Intellectual Property Litigation
HSMN NewsFeed - 1 May 2020
Suneva Medical Increases Its Leadership in Regenerative Aesthetics with New Partnership
Suneva Medical Increases Its Leadership in Regenerative Aesthetics with New Partnership
HSMN NewsFeed - 10 Mar 2020
TriGUARD 3(TM) Cerebral Embolic Protection Device Receives CE Mark for Use in Transcatheter Heart Procedures
TriGUARD 3(TM) Cerebral Embolic Protection Device Receives CE Mark for Use in Transcatheter Heart Procedures
HSMN NewsFeed - 1 Jul 2019
Squarex Appoints Biopharmaceutical Industry Veteran Jack V. Talley as Chief Executive Officer
Squarex Appoints Biopharmaceutical Industry Veteran Jack V. Talley as Chief Executive Officer
HSMN NewsFeed - 16 Apr 2019
Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors
Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors
HSMN NewsFeed - 4 Jan 2019
Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary
Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary
HSMN NewsFeed - 1 Oct 2018
Orexo Internalizes Contract Field Force in the US to Further Strengthen the Commercial Organization
Orexo Internalizes Contract Field Force in the US to Further Strengthen the Commercial Organization
HSMN NewsFeed - 27 Aug 2018
Tris Pharma Announces Hiring of New Vice President of Quality & Compliance
Tris Pharma Announces Hiring of New Vice President of Quality & Compliance
HSMN NewsFeed - 20 Jun 2018
Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary(R)
Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary(R)
HSMN NewsFeed - 28 Apr 2017
Venus Medtech's TAVR Device Is Approved By CFDA, Creating A New Era Of Interventional Cardiology In China
Venus Medtech's TAVR Device Is Approved By CFDA, Creating A New Era Of Interventional Cardiology In China
HSMN NewsFeed - 7 Feb 2017
Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer, Succeeding Erez Vigodman
Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer, Succeeding Erez Vigodman
HSMN NewsFeed - 9 Jan 2017
Xeris Pharmaceuticals Announces Appointment of Paul R. Edick as President and CEO
Xeris Pharmaceuticals Announces Appointment of Paul R. Edick as President and CEO
HSMN NewsFeed - 3 Jan 2017
Allergan Announces FDA Approval of NATRELLE INSPIRA(R) SoftTouch Breast Implants
Allergan Announces FDA Approval of NATRELLE INSPIRA(R) SoftTouch Breast Implants
HSMN NewsFeed - 2 Dec 2016
Allergan Announces Settlement of a DELZICOL(R) (mesalamine) Patent Litigation
Allergan Announces Settlement of a DELZICOL(R) (mesalamine) Patent Litigation
HSMN NewsFeed - 22 Nov 2016
Allergan Receives FDA Clearance for the XEN(R) Gel Stent, a New Surgical Treatment for Refractory Glaucoma
Allergan Receives FDA Clearance for the XEN(R) Gel Stent, a New Surgical Treatment for Refractory Glaucoma
HSMN NewsFeed - 29 Sep 2016
Allergan Issues Statement on Namenda XR Patent Litigation Following Announcement of ANDA Approvals
Allergan Issues Statement on Namenda XR Patent Litigation Following Announcement of ANDA Approvals
HSMN NewsFeed - 31 Aug 2016
Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC(R) Patent Litigation
Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC(R) Patent Litigation
HSMN NewsFeed - 3 Aug 2016
Allergan Announces Sale of Anda Distribution Business to Teva Pharmaceutical
Allergan Announces Sale of Anda Distribution Business to Teva Pharmaceutical
HSMN NewsFeed - 15 Jun 2016
German Supreme Court Grants Lilly Appeal in Alimta(R) Vitamin Regimen Patent Lawsuit
German Supreme Court Grants Lilly Appeal in Alimta(R) Vitamin Regimen Patent Lawsuit
HSMN NewsFeed - 8 Jun 2016
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
HSMN NewsFeed - 31 May 2016
Allergan Receives FDA Approval of TEFLARO(R) (ceftaroline fosamil) for Pediatric Patients
Allergan Receives FDA Approval of TEFLARO(R) (ceftaroline fosamil) for Pediatric Patients
HSMN NewsFeed - 24 May 2016
Allergan Announces FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0%
Allergan Announces FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0%
HSMN NewsFeed - 16 May 2016
Allergan Announces Positive Pivotal Trial Results for Oculeve Intranasal Tear Neurostimulator
Allergan Announces Positive Pivotal Trial Results for Oculeve Intranasal Tear Neurostimulator
HSMN NewsFeed - 2 May 2016
Endo Announces U.S. District Court Ruling Upholding OPANA(R) ER Intellectual Property
Endo Announces U.S. District Court Ruling Upholding OPANA(R) ER Intellectual Property
HSMN NewsFeed - 2 May 2016
Allergan Receives FDA Approval and Launches First Generic Version of CRESTOR(R) (rosuvastatin)
Allergan Receives FDA Approval and Launches First Generic Version of CRESTOR(R) (rosuvastatin)
HSMN NewsFeed - 7 Mar 2016
Anthera Pharmaceuticals Announces Appointment of Dr. James Pennington as Interim Chief Medical Officer
Anthera Pharmaceuticals Announces Appointment of Dr. James Pennington as Interim Chief Medical Officer
HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
HSMN NewsFeed - 29 Feb 2016
Allergan Announces Receipt Of FDA Acceptable For Filing Letter For Generic XIFAXAN(R) ANDA
Allergan Announces Receipt Of FDA Acceptable For Filing Letter For Generic XIFAXAN(R) ANDA
HSMN NewsFeed - 16 Feb 2016
FDA Accepts Supplemental New Drug Application (sNDA) for TEFLARO(R) (ceftaroline fosamil)
FDA Accepts Supplemental New Drug Application (sNDA) for TEFLARO(R) (ceftaroline fosamil)
HSMN NewsFeed - 22 Jan 2016
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
HSMN NewsFeed - 21 Jan 2016
Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for DALVANCE(R) (dalbavancin)
Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for DALVANCE(R) (dalbavancin)
HSMN NewsFeed - 21 Jan 2016
VIBERZI(TM) (eluxadoline) Phase III Trial Results Published in The New England Journal of Medicine
VIBERZI(TM) (eluxadoline) Phase III Trial Results Published in The New England Journal of Medicine
HSMN NewsFeed - 4 Nov 2015
Allergan to Acquire earFold(TM), an Innovative Medical Device for the Correction of Prominent Ears
Allergan to Acquire earFold(TM), an Innovative Medical Device for the Correction of Prominent Ears
HSMN NewsFeed - 29 Oct 2015
Allergan plc Confirms Discussions Regarding Potential Business Combination Transaction With Pfizer Inc.
Allergan plc Confirms Discussions Regarding Potential Business Combination Transaction With Pfizer Inc.
HSMN NewsFeed - 27 Oct 2015
Allergan Acquires Rights To Ironwood's CONSTELLA(R) (Linaclotide) From Almirall In More Than 40 Countries
Allergan Acquires Rights To Ironwood's CONSTELLA(R) (Linaclotide) From Almirall In More Than 40 Countries
HSMN NewsFeed - 15 Sep 2015
Depomed Files New Patent Infringement Lawsuit Against NUCYNTA(R) ER ANDA Filer
Depomed Files New Patent Infringement Lawsuit Against NUCYNTA(R) ER ANDA Filer
HSMN NewsFeed - 24 Apr 2015
Cipher Pharmaceuticals announces outcome of Markman hearing in patent infringement suit for Absorica(R)
Cipher Pharmaceuticals announces outcome of Markman hearing in patent infringement suit for Absorica(R)
HSMN NewsFeed - 13 Apr 2015
Depomed Announces Gralise(R) ANDA Litigation Settlement Confirming Exclusivity to 2024 and Dismissing Appeal
Depomed Announces Gralise(R) ANDA Litigation Settlement Confirming Exclusivity to 2024 and Dismissing Appeal
HSMN NewsFeed - 18 Nov 2014
Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer
Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer
HSMN NewsFeed - 10 Oct 2014
Vernalis Opens US Office and Strengthens US Team With the Appointment of SVP Medical Affairs
Vernalis Opens US Office and Strengthens US Team With the Appointment of SVP Medical Affairs
HSMN NewsFeed - 15 Sep 2014
Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer
Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer
HSMN NewsFeed - 1 Jul 2014
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
HSMN NewsFeed - 22 May 2014
Primary Endpoint Data Presented on Performance and Safety of the JenaValve TAVI System
Primary Endpoint Data Presented on Performance and Safety of the JenaValve TAVI System
HSMN NewsFeed - 18 Feb 2014
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction
HSMN NewsFeed - 14 Jan 2014
Actavis Appoints Industry Veterans to Lead U.S. Specialty Brands Business Units
Actavis Appoints Industry Veterans to Lead U.S. Specialty Brands Business Units
HSMN NewsFeed - 19 Nov 2013
Antares Pharma Appoints David H. Bergstrom Ph.D. as Senior Vice President Pharmaceutical Development
Antares Pharma Appoints David H. Bergstrom Ph.D. as Senior Vice President Pharmaceutical Development
HSMN NewsFeed - 15 Nov 2013
Boston Scientific Announces First Commercial Implants Of The Lotus(TM) Valve System in Europe
Boston Scientific Announces First Commercial Implants Of The Lotus(TM) Valve System in Europe
HSMN NewsFeed - 9 Sep 2013
Keystone Heart's TriGuard(TM) Cerebral Protection Device Receives CE Marking
Keystone Heart's TriGuard(TM) Cerebral Protection Device Receives CE Marking
HSMN NewsFeed - 3 Sep 2013
Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
HSMN NewsFeed - 12 Aug 2013
Elite Pharmaceuticals, Inc. Hires Industry Veteran Doug Plassche as Executive Vice President of Operations
Elite Pharmaceuticals, Inc. Hires Industry Veteran Doug Plassche as Executive Vice President of Operations
HSMN NewsFeed - 22 Jul 2013
Forest Laboratories, Inc. Announces Additional Settlement Agreement in BYSTOLIC(R) Patent Litigation
Forest Laboratories, Inc. Announces Additional Settlement Agreement in BYSTOLIC(R) Patent Litigation
HSMN NewsFeed - 19 Jun 2013
Actavis And Kissei File Lawsuits Against Sandoz And Hetero For Infringement Of Rapaflo(R) Patent
Actavis And Kissei File Lawsuits Against Sandoz And Hetero For Infringement Of Rapaflo(R) Patent
HSMN NewsFeed - 21 May 2013
Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system
Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system
HSMN NewsFeed - 1 May 2013
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel
HSMN NewsFeed - 6 Feb 2013
Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Naltrexone
Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Naltrexone
HSMN NewsFeed - 5 Feb 2013
Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Actavis
Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Actavis
HSMN NewsFeed - 25 Jan 2013
FDA Approves OXYTROL(R) FOR WOMEN, the First Over-the-Counter Treatment for Overactive Bladder in Women
FDA Approves OXYTROL(R) FOR WOMEN, the First Over-the-Counter Treatment for Overactive Bladder in Women
HSMN NewsFeed - 17 Oct 2012
Loma Vista Medical Receives FDA Clearance for its TRUE Dilatation(TM) Balloon Valvuloplasty Catheter
Loma Vista Medical Receives FDA Clearance for its TRUE Dilatation(TM) Balloon Valvuloplasty Catheter
HSMN NewsFeed - 10 May 2012
Loma Vista Medical receives CE mark for its TRUE Dilatation(TM) Balloon Valvuloplasty Catheter
Loma Vista Medical receives CE mark for its TRUE Dilatation(TM) Balloon Valvuloplasty Catheter
HSMN NewsFeed - 27 Apr 2012
Watson Announces Restructuring of Senior Leadership to Support Expanded Global Businesses
Watson Announces Restructuring of Senior Leadership to Support Expanded Global Businesses
HSMN NewsFeed - 4 Nov 2011
Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011
Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011
HSMN NewsFeed - 18 Oct 2011
Colibri Heart Valve, LLC Announces Appointment of Joseph B. Horn, President and CEO
Colibri Heart Valve, LLC Announces Appointment of Joseph B. Horn, President and CEO
HSMN NewsFeed - 13 Oct 2011
ISTA Pharmaceuticals Announces Statistically Significant Phase 3 Results for PROLENSA(TM)
ISTA Pharmaceuticals Announces Statistically Significant Phase 3 Results for PROLENSA(TM)
HSMN NewsFeed - 6 Sep 2011
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
HSMN NewsFeed - 7 Jun 2011
St. Jude Medical Announces First Implant of Portico Transcatheter Heart Valve
St. Jude Medical Announces First Implant of Portico Transcatheter Heart Valve
HSMN NewsFeed - 19 May 2011
Study Provides Insight on Medtronic CoreValve(R) System Implants Through Subclavian Approach
Study Provides Insight on Medtronic CoreValve(R) System Implants Through Subclavian Approach
HSMN NewsFeed - 21 Mar 2011
Lithera Announces the Appointment of George W. Mahaffey as President and Chief Executive Officer
Lithera Announces the Appointment of George W. Mahaffey as President and Chief Executive Officer
HSMN NewsFeed - 18 Feb 2011
Largest Study of Medtronic CoreValve(R) System Confirms Positive Clinical Outcomes
Largest Study of Medtronic CoreValve(R) System Confirms Positive Clinical Outcomes
HSMN NewsFeed - 11 Jan 2011
St. Francis Hospital to be Part of Major Nationwide Study Using a Catheter-Based Aortic Valve Replacement
St. Francis Hospital to be Part of Major Nationwide Study Using a Catheter-Based Aortic Valve Replacement
HSMN NewsFeed - 7 Jan 2011
CardiAQ Valve Technologies (CVT) appoints Rob Michiels as Chief Executive Officer
CardiAQ Valve Technologies (CVT) appoints Rob Michiels as Chief Executive Officer
HSMN NewsFeed - 2 Nov 2010
JenaValve Technology Initiates Multicenter CE-Mark Study for Its Transapical TAVI System
JenaValve Technology Initiates Multicenter CE-Mark Study for Its Transapical TAVI System
HSMN NewsFeed - 29 Oct 2010
APP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USP
APP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USP
HSMN NewsFeed - 7 Sep 2010
Medtronic Gains CE Mark for Enhanced CoreValve(R) Delivery Catheter System with AccuTrak Stability Layer
Medtronic Gains CE Mark for Enhanced CoreValve(R) Delivery Catheter System with AccuTrak Stability Layer
HSMN NewsFeed - 4 Aug 2010
Watson Names Sigurdur Oli Olafsson Executive Vice President, Global Generics
Watson Names Sigurdur Oli Olafsson Executive Vice President, Global Generics
HSMN NewsFeed - 21 Jun 2010
APP Pharmaceuticals Announces Approval and Launch of First Generic Aztreonam for Injection, USP
APP Pharmaceuticals Announces Approval and Launch of First Generic Aztreonam for Injection, USP
HSMN NewsFeed - 19 May 2010
Embrella Cardiovascular, Inc. Receives European CE Mark Approval for the Embrella Embolic Deflector Device
Embrella Cardiovascular, Inc. Receives European CE Mark Approval for the Embrella Embolic Deflector Device
HSMN NewsFeed - 5 Jan 2010
Embrella Cardiovascular, Inc. Completes Successful First Clinical Experience
Embrella Cardiovascular, Inc. Completes Successful First Clinical Experience
HSMN NewsFeed - 26 Oct 2009
FDA Determines VYVANSE(R) was Properly Granted Five-Year Market Exclusivity
FDA Determines VYVANSE(R) was Properly Granted Five-Year Market Exclusivity
HSMN NewsFeed - 21 May 2008
AVANT Immunotherapeutics Announces Hart-Scott Rodino Clearance to License Cancer Vaccine to Pfizer
AVANT Immunotherapeutics Announces Hart-Scott Rodino Clearance to License Cancer Vaccine to Pfizer
HSMN NewsFeed - 28 Mar 2008
Actavis Receives Approval of Generic Wellbutrin SR(R) and Zyban(R) Tablets in the U.S.
Actavis Receives Approval of Generic Wellbutrin SR(R) and Zyban(R) Tablets in the U.S.
HSMN NewsFeed - 26 Nov 2007
Bio-advancements Expected to Drive Burn Care Market Growth Up $700 Million
Bio-advancements Expected to Drive Burn Care Market Growth Up $700 Million
HSMN NewsFeed - 15 Nov 2007
High-price Vaccines Spark Four-fold Growth in Pediatric & Adolescent Vaccines Market
High-price Vaccines Spark Four-fold Growth in Pediatric & Adolescent Vaccines Market
HSMN NewsFeed - 22 Oct 2007
AVANT Immunotherapeutics, Inc. and Celldex Therapeutics, Inc. Announce Merger Agreement
AVANT Immunotherapeutics, Inc. and Celldex Therapeutics, Inc. Announce Merger Agreement
HSMN NewsFeed - 4 Oct 2007
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
HSMN NewsFeed - 14 Aug 2007
GlaxoSmithKline's Application for Rotarix(R) is Accepted for Review by the FDA
GlaxoSmithKline's Application for Rotarix(R) is Accepted for Review by the FDA
HSMN NewsFeed - 21 Mar 2007
ADDERALL XR(R) - Shire Files Suit Against Colony Pharmaceuticals, Inc., Actavis, Inc. and Actavis Group hf
ADDERALL XR(R) - Shire Files Suit Against Colony Pharmaceuticals, Inc., Actavis, Inc. and Actavis Group hf
HSMN NewsFeed - 10 Jan 2007
Endovasc Strengthens Management Team by Appointing Chief Financial and Chief Compliance Officer
Endovasc Strengthens Management Team by Appointing Chief Financial and Chief Compliance Officer
HSMN NewsFeed - 13 Dec 2006
Exercise and Physical Rehabilitation Specialist Joins Endovasc's Board of Directors
Exercise and Physical Rehabilitation Specialist Joins Endovasc's Board of Directors
HSMN NewsFeed - 20 Nov 2006
Actelion Announces Definitive Agreement to Acquire U.S.-Based CoTherix, Inc.
Actelion Announces Definitive Agreement to Acquire U.S.-Based CoTherix, Inc.
HSMN NewsFeed - 29 Sep 2006
Mathematical Model Predicts That CERVARIX May Prevent Nearly 80 Percent of Cervical Cancers
Mathematical Model Predicts That CERVARIX May Prevent Nearly 80 Percent of Cervical Cancers
HSMN NewsFeed - 22 Sep 2006
Merck and Nicaragua Unveil New Rotavirus Vaccine Demonstration Project at Clinton Global Initiative
Merck and Nicaragua Unveil New Rotavirus Vaccine Demonstration Project at Clinton Global Initiative
HSMN NewsFeed - 8 Jun 2006
FDA Approves Merck's GARDASIL(R), the World's First and Only Cervical Cancer Vaccine
FDA Approves Merck's GARDASIL(R), the World's First and Only Cervical Cancer Vaccine
HSMN NewsFeed - 26 May 2006
FDA Approves ZOSTAVAX(R), Merck's New Vaccine for Prevention of Shingles in Adults Age 60 and Older
FDA Approves ZOSTAVAX(R), Merck's New Vaccine for Prevention of Shingles in Adults Age 60 and Older
HSMN NewsFeed - 8 May 2006
Endovasc Announces Agreement with PYRAMID Labs to Manufacture Liprostin for Phase IIIa Trial
Endovasc Announces Agreement with PYRAMID Labs to Manufacture Liprostin for Phase IIIa Trial
HSMN NewsFeed - 27 Feb 2006
AVANT Announces that the European Regulatory Authorities Have Approved Rotarix(R) Rotavirus Vaccine
AVANT Announces that the European Regulatory Authorities Have Approved Rotarix(R) Rotavirus Vaccine
HSMN NewsFeed - 4 Jan 2006
GlaxoSmithKline's Rotavirus Vaccine Candidate Shown Effective Against Rotavirus Disease
GlaxoSmithKline's Rotavirus Vaccine Candidate Shown Effective Against Rotavirus Disease
Additional items found! 108

Members Archive contains
108 additional stories matching:
TAVI
(Password required)
TAVI
(Password required)